Oguz Kilinc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oguz Kilinc has a total of 289 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Sayiner
Department of Pulmonology, İzmir University of Economics Faculty of Medicine, İzmir, Turkey
10 shared publications - Osman Elbek
Clinic of Chest Diseases Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital İstanbul Türkiye
6 shared publications - Pelin Duru Çetinkaya
Department of Pulmonary Medicine, Faculty of Medicine, Cukurova University, Adana 01790, Türkiye
6 shared publications - Begüm Ergan
Department of Pulmonary and Critical Care, Dokuz Eylül University School of Medicine, İzmir, Turkey
5 shared publications - Sedat Altin
Department of Chest Disease, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
5 shared publications - Seval Kul
Department of Biostatistics, Faculty of Medicine, Gaziantep University, Gaziantep 27310, Türkiye
5 shared publications
Latest Publications
- Open Access
- 26 September 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Benign Symptom Framing and Chatbot Escalation Advice After Smoking Cessation: A Paired Turkish-Language Vignette Study (Preprint)
BACKGROUND People seeking advice after quitting smoking may suggest that respiratory or chest symptoms reflect normal recovery. Consumer chatbots need to distinguish that explanation from the action required by the symptoms described. Reassuring language and safety-net advice do not necessarily establish an appropriate recommendation for current symptoms. OBJECTIVE To examine whether benign explanatory framing changes the frequency of insufficient escalation in Turkish-language chatbot advice after smoking cessation, and to describe differences between products and repeated responses. METHODS CLEAR-QUIT evaluated 24 synthetic scenarios, comprising eight emergency, eight urgent, and eight routine/self-care scenarios. ChatGPT, Gemini, Claude, Grok, and DeepSeek received neutral and benign-framed versions in two administrations, producing 480 responses. AI-assisted outcome codes were reviewed by an expert in smoking cessation using blinded materials. The primary comparison used 16 first-administration emergency/urgent scenarios, with 80 responses per framing. Insufficient escalation combined advice below the reference urgency, unclear urgency, or conflicting delay. We estimated equally weighted scenario-level risk differences with scenario-block bootstrap 95% confidence intervals and exact sign-flip tests. Post hoc product comparisons specified in a separate plan used Holm correction. RESULTS Insufficient escalation occurred in 29/80 neutral responses (36.3%) and 26/80 benign-framed responses (32.5%): risk difference −3.75 percentage points (95% CI −13.75 to 6.25; P=.637). Emergency-scenario failures were 0/40 versus 4/40; urgent-scenario failures were 29/40 versus 22/40. These strata were exploratory. Accepting broader urgent-timing language changed the pooled difference to 2.50 points (95% CI −6.25 to 11.25). Observed product risks ranged from 7/32 to 15/32, but no pairwise comparison met the Holm-adjusted threshold. Across all responses, 421/480 (87.7%) included safety-netting and none advised restarting smoking. Repeat-administration triage agreement was 210/240 (87.5%). CONCLUSIONS This benchmark did not establish an overall increase in insufficient escalation under benign framing; its confidence interval allowed effects in either direction. Urgent-advice classification depended on the timing rule. Chatbot health-information evaluations should assess the recommended action and timeframe alongside supportive content. These results do not establish product equivalence or safety in clinical use.
- 26 September 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessBenign Symptom Framing and Chatbot Escalation Advice After Smoking Cessation: A Paired Turkish-Language Vignette Study (Preprint)
BACKGROUND People seeking advice after quitting smoking may suggest that respiratory or chest symptoms reflect normal recovery. Consumer chatbots need to distinguish that explanation from the action required by the symptoms described. Reassuring language and safety-net advice do not necessarily establish an appropriate recommendation for current symptoms. OBJECTIVE To examine whether benign explanatory framing changes the frequency of insufficient escalation in Turkish-language chatbot advice after smoking cessation, and to describe differences between products and repeated responses. METHODS CLEAR-QUIT evaluated 24 synthetic scenarios, comprising eight emergency, eight urgent, and eight routine/self-care scenarios. ChatGPT, Gemini, Claude, Grok, and DeepSeek received neutral and benign-framed versions in two administrations, producing 480 responses. AI-assisted outcome codes were reviewed by an expert in smoking cessation using blinded materials. The primary comparison used 16 first-administration emergency/urgent scenarios, with 80 responses per framing. Insufficient escalation combined advice below the reference urgency, unclear urgency, or conflicting delay. We estimated equally weighted scenario-level risk differences with scenario-block bootstrap 95% confidence intervals and exact sign-flip tests. Post hoc product comparisons specified in a separate plan used Holm correction. RESULTS Insufficient escalation occurred in 29/80 neutral responses (36.3%) and 26/80 benign-framed responses (32.5%): risk difference −3.75 percentage points (95% CI −13.75 to 6.25; P=.637). Emergency-scenario failures were 0/40 versus 4/40; urgent-scenario failures were 29/40 versus 22/40. These strata were exploratory. Accepting broader urgent-timing language changed the pooled difference to 2.50 points (95% CI −6.25 to 11.25). Observed product risks ranged from 7/32 to 15/32, but no pairwise comparison met the Holm-adjusted threshold. Across all responses, 421/480 (87.7%) included safety-netting and none advised restarting smoking. Repeat-administration triage agreement was 210/240 (87.5%). CONCLUSIONS This benchmark did not establish an overall increase in insufficient escalation under benign framing; its confidence interval allowed effects in either direction. Urgent-advice classification depended on the timing rule. Chatbot health-information evaluations should assess the recommended action and timeframe alongside supportive content. These results do not establish product equivalence or safety in clinical use.
- Open Access
- 30 April 2026
- Published by European Publishing in Tobacco Induced Diseases
- Vol. 24 (April) , 1-9
Democracy, gender equality, advanced civil rights, economic welfare, and equitable distribution of wealth are related to the success of tobacco control
Introduction: It is well known that there are many social and economic factors influencing tobacco use. There are very few studies addressing these aspects of the issue. Nevertheless, smoking is closely related to social, economic, cultural, and political factors. This study aims to present the...
- 30 April 2026
- Published by European Publishing in Tobacco Induced Diseases
- Vol. 24 (April) , 1-9
Open AccessDemocracy, gender equality, advanced civil rights, economic welfare, and equitable distribution of wealth are related to the success of tobacco control
Introduction: It is well known that there are many social and economic factors influencing tobacco use. There are very few studies addressing these aspects of the issue. Nevertheless, smoking is closely related to social, economic, cultural, and political factors. This study aims to present the...
- 17 February 2026
- Published by Academician Publishing
- p. 149-152
Bilimsel Makalelerde Şeffaflık
Bilimsel makalelerde şeffaflık konusu uzun yıllardır gündemde olan ve günümüzde de farklı boyutlarıyla tartışılan bir konudur. Bu yazıda bilimsel makalelerde şeffaflık ile ilgili tartışmalar, bilimsel makalelerdeki şeffaflığın bilime katkıları, şeffaflık beyanı bileşenleri konu edilmiştir. Transparency in scientific articles has been a topic of discussion for many years and continues to be debated in various aspects today. This article examines the debates surrounding transparency in scientific articles, its contributions to science, and the components of transparency statements.
- 17 February 2026
- Published by Academician Publishing
- p. 149-152
Bilimsel Makalelerde Şeffaflık
Bilimsel makalelerde şeffaflık konusu uzun yıllardır gündemde olan ve günümüzde de farklı boyutlarıyla tartışılan bir konudur. Bu yazıda bilimsel makalelerde şeffaflık ile ilgili tartışmalar, bilimsel makalelerdeki şeffaflığın bilime katkıları, şeffaflık beyanı bileşenleri konu edilmiştir. Transparency in scientific articles has been a topic of discussion for many years and continues to be debated in various aspects today. This article examines the debates surrounding transparency in scientific articles, its contributions to science, and the components of transparency statements.
- Open Access
- 30 January 2026
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 27 (1) , 68-74
Turkish Thoracic Society Declaration on Peace and Health the Importance of Breathing in a World Without War
Turkish Thoracic Society Declaration on Peace and Health the Importance of Breathing in a World Without War - Thoracic Research and Practice
- 30 January 2026
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 27 (1) , 68-74
Open AccessTurkish Thoracic Society Declaration on Peace and Health the Importance of Breathing in a World Without War
Turkish Thoracic Society Declaration on Peace and Health the Importance of Breathing in a World Without War - Thoracic Research and Practice
- Open Access
- 29 January 2026
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 43 (3) , 113-114
Echoes of the Past: Are E-Cigarettes the New "Light" Cigarettes?
- 29 January 2026
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 43 (3) , 113-114
Open AccessEchoes of the Past: Are E-Cigarettes the New "Light" Cigarettes?
- Open Access
- 20 January 2026
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 27 (1) , 75-76
The Necessity of Bronchiectasis Registries - The Turkish Registry of Bronchiectasis
The Necessity of Bronchiectasis Registries - The Turkish Registry of Bronchiectasis - Thoracic Research and Practice
- 20 January 2026
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 27 (1) , 75-76
Open AccessThe Necessity of Bronchiectasis Registries - The Turkish Registry of Bronchiectasis
The Necessity of Bronchiectasis Registries - The Turkish Registry of Bronchiectasis - Thoracic Research and Practice
- Open Access
- 3 June 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (5) , 262-263
Response to: Effectiveness of a Program to Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients with Chronic Respiratory Diseases: A Multicenter Cohort Study
Response to: Effectiveness of a Program to Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients with Chronic Respiratory Diseases: A Multicenter Cohort Study - Thoracic Research and Practice
- 3 June 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (5) , 262-263
Open AccessResponse to: Effectiveness of a Program to Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients with Chronic Respiratory Diseases: A Multicenter Cohort Study
Response to: Effectiveness of a Program to Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients with Chronic Respiratory Diseases: A Multicenter Cohort Study - Thoracic Research and Practice
- Open Access
- 7 November 2024
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (1) , 40-41
Could E-Cigarettes be the Source of Lead Toxicity?
- 7 November 2024
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (1) , 40-41
Open AccessCould E-Cigarettes be the Source of Lead Toxicity?
- Open Access
- 27 August 2024
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (2) , 75-81
Effectiveness of a Program to Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients with Chronic Respiratory Diseases: A Multicenter Cohort Study
65-year-old,chronic obstructive pulmonary disease,mortality,pneumonia,pneumococcal vaccination
- 27 August 2024
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (2) , 75-81
Open AccessEffectiveness of a Program to Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients with Chronic Respiratory Diseases: A Multicenter Cohort Study
65-year-old,chronic obstructive pulmonary disease,mortality,pneumonia,pneumococcal vaccination
- Open Access
- 14 March 2024
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 11 (1) , 30-35
Retrospective evaluation of COVID-19 incidence during smoking cessation treatment with varenicline
CBU-SBED: Celal Bayar University-Health Sciences Institute Journal | Volume: 11 Issue: 1
- 14 March 2024
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 11 (1) , 30-35
Open AccessRetrospective evaluation of COVID-19 incidence during smoking cessation treatment with varenicline
CBU-SBED: Celal Bayar University-Health Sciences Institute Journal | Volume: 11 Issue: 1